![]() Neoadjuvant & adjuvant therapy for rectal cancer.Irinotecan and targeted agents (Stage II-III colon).Adjuvant therapy for elderly stage III CRC (ADJ1).Introduction: adjuvant therapy for colon cancer.Peritonectomy with hyperthermic intraperitoneal chemotherapy (COLMNG3).Emergency management of malignant large bowel obstruction (COLMNG5).Local versus radical resection for T1-T2 rectal tumours (REC3).Optimal approach to elective resection for rectal cancers (COL1-2b).Introduction: elective resection for rectal cancers.Optimal approach to elective resection for rectal cancers.Optimal approach to elective resection for colon cancers (COL1-2a).Elective and emergency surgery for colon and rectal cancer.Mechanical bowel prep and antibiotic prophylaxis.Introduction: preparation for surgery and perioperative optimisation.Preparation for surgery and perioperative optimisation.Additional information on pathology reporting.Post-surgical staging following neoadjuvant therapy.Imaging a patient with a diagnosis of CRC.State- and territory-based familial cancer registries Introduction: high-risk familial syndromes.Screening strategies for people with a family history of colorectal cancer.Colorectal cancer risk according to family history (FHS2). ![]() Introduction: Risk and screening based on family history.Risk and screening based on family history. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |